Circadin is for the short-term treatment of primary insomnia in patients aged 55 years or over. Primary Insomnia is insomnia without any medical cause or other clear cause. Circadin contains melatonin in a prolonged release form to help improve sleep quality.
Circadin specifically designed prolonged release formulation enables the gradual release of melatonin over 8-10 hours, in order to mimic the body’s natural patterns of melatonin secretion at night. This in turn helps you fall asleep, maintain sleep, improve sleep quality and morning alertness, to feel restored the next day.
AUST R 153959